Impact on corneal morphology after cataract surgery with intracameral moxifloxacin in neglected hard cataracts

Impact on corneal morphology after cataract surgery with intracameral moxifloxacin in neglected hard cataracts

Aim To evaluate corneal morphology after use of 0.5% intracameral moxifloxacin (ICM) in cataract surgery in patients who presented late with hard cataracts. Methods Cross-sectional study conducted from June-2021 to December-2021 at a tertiary eye-care center. 90 patients over 60 years with high-risk...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of ophthalmology 2023-03, Vol.33 (2), p.919-926
Hauptverfasser: Gupta, Simple, Vichare, Nitin, Kumar, Praveen, Agrawal, Mohini, C.M., Anushree, Singh, Manish
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 926
container_issue 2
container_start_page 919
container_title European journal of ophthalmology
container_volume 33
creator Gupta, Simple
Vichare, Nitin
Kumar, Praveen
Agrawal, Mohini
C.M., Anushree
Singh, Manish
description Aim To evaluate corneal morphology after use of 0.5% intracameral moxifloxacin (ICM) in cataract surgery in patients who presented late with hard cataracts. Methods Cross-sectional study conducted from June-2021 to December-2021 at a tertiary eye-care center. 90 patients over 60 years with high-risk characteristics for Covid-19, who presented late with higher grades of nuclear-sclerosis (NS), were included. They underwent phacoemulsification and 0.5%moxifloxacin (0.1 ml) was injected intracamerally at the end of surgery. Best-corrected visual acuity (BCVA), intraocular pressures (IOP), endothelial cell density (ECD), coefficient of variation in cell-area (CoV), hexagonality (Hex) and central corneal thickness (CCT) were measured preoperatively and postoperatively on day1, day7 and day30. Statistical analysis was done by Anova test. p-value
doi_str_mv 10.1177/11206721221124673
format Article
fullrecord <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1177_11206721221124673</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_11206721221124673</sage_id><sourcerecordid>10.1177_11206721221124673</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-ab080eb109fc8308d94a7960de93a1abe27b9b4894cba9736f568bf1a001a3f93</originalsourceid><addsrcrecordid>eNp9kEtLAzEUhYMotlZ_gBvJH5iaV5PJUoqPQsGNroebTDKdMi-SKbb_3tSqG8HVvdzznQP3IHRLyZxSpe4pZUQqRhlLm5CKn6EpVUxkklB5nvakZ0dggq5i3BLCiBbsEk24JAsmqJ6ibtUOYEfcd9j2oXPQ4LYPw6Zv-uqAwY8uYAsjhCMUd6Fy4YA_6nGD625MR2hd-PLsa9_0e7B1lxTcuapxdnQl3kAofxPiNbrw0ER38z1n6P3p8W35kq1fn1fLh3VmuSBjBobkxBlKtLc5J3mpBSgtSek0BwrGMWW0EbkW1oBWXPqFzI2nQAgF7jWfIXrKtaGPMThfDKFuIRwKSopjd8Wf7pLn7uQZdqZ15a_jp6wEzE9AhMoV234XuvTDP4mfC0B44g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Impact on corneal morphology after cataract surgery with intracameral moxifloxacin in neglected hard cataracts</title><source>SAGE Complete</source><creator>Gupta, Simple ; Vichare, Nitin ; Kumar, Praveen ; Agrawal, Mohini ; C.M., Anushree ; Singh, Manish</creator><creatorcontrib>Gupta, Simple ; Vichare, Nitin ; Kumar, Praveen ; Agrawal, Mohini ; C.M., Anushree ; Singh, Manish</creatorcontrib><description>Aim To evaluate corneal morphology after use of 0.5% intracameral moxifloxacin (ICM) in cataract surgery in patients who presented late with hard cataracts. Methods Cross-sectional study conducted from June-2021 to December-2021 at a tertiary eye-care center. 90 patients over 60 years with high-risk characteristics for Covid-19, who presented late with higher grades of nuclear-sclerosis (NS), were included. They underwent phacoemulsification and 0.5%moxifloxacin (0.1 ml) was injected intracamerally at the end of surgery. Best-corrected visual acuity (BCVA), intraocular pressures (IOP), endothelial cell density (ECD), coefficient of variation in cell-area (CoV), hexagonality (Hex) and central corneal thickness (CCT) were measured preoperatively and postoperatively on day1, day7 and day30. Statistical analysis was done by Anova test. p-value&lt;0.05 was considered significant. Results Mean age of presentation was 65.26±8.3 years. Mean preoperative BCVA (1/60-to-6/60), IOP (16.7±2.3 mm of Hg), CCT (523.93±39.6µ), ECD (2547±302.08cells/mm2), Hex (47.04±5.7%) and CoV (37.57±3.9) changed to BCVA (6/9-to-6/6), IOP (17.5±2.1 mm of Hg), CCT (538.42±36.9µ), ECD (2388.40±339.25cells/mm2), Hex (44.44±5.6%) and CoV (39.09±4.5) at day30 postoperative. Average rate of change at day30 was increase in CCT (2.89%), ECD loss (6.4%), decrease in Hex (4.9%) and increase in CoV (4.6%), though clinically insignificant. No case of endophthalmitis or toxic-anterior segment syndrome seen. Conclusion 0.5% moxifloxacin (0.1 ml) is safe as intracameral antibiotic to prevent postoperative infection in high-risk patients. The reported changes in the corneal parameters were within the range of any routine surgeries of hard senile cataracts. No specific effect could be attributed to ICM.</description><identifier>ISSN: 1120-6721</identifier><identifier>EISSN: 1724-6016</identifier><identifier>DOI: 10.1177/11206721221124673</identifier><identifier>PMID: 36052419</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><ispartof>European journal of ophthalmology, 2023-03, Vol.33 (2), p.919-926</ispartof><rights>The Author(s) 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-ab080eb109fc8308d94a7960de93a1abe27b9b4894cba9736f568bf1a001a3f93</citedby><cites>FETCH-LOGICAL-c340t-ab080eb109fc8308d94a7960de93a1abe27b9b4894cba9736f568bf1a001a3f93</cites><orcidid>0000-0002-4510-0668</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/11206721221124673$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/11206721221124673$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36052419$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gupta, Simple</creatorcontrib><creatorcontrib>Vichare, Nitin</creatorcontrib><creatorcontrib>Kumar, Praveen</creatorcontrib><creatorcontrib>Agrawal, Mohini</creatorcontrib><creatorcontrib>C.M., Anushree</creatorcontrib><creatorcontrib>Singh, Manish</creatorcontrib><title>Impact on corneal morphology after cataract surgery with intracameral moxifloxacin in neglected hard cataracts</title><title>European journal of ophthalmology</title><addtitle>European Journal of Ophthalmology</addtitle><description>Aim To evaluate corneal morphology after use of 0.5% intracameral moxifloxacin (ICM) in cataract surgery in patients who presented late with hard cataracts. Methods Cross-sectional study conducted from June-2021 to December-2021 at a tertiary eye-care center. 90 patients over 60 years with high-risk characteristics for Covid-19, who presented late with higher grades of nuclear-sclerosis (NS), were included. They underwent phacoemulsification and 0.5%moxifloxacin (0.1 ml) was injected intracamerally at the end of surgery. Best-corrected visual acuity (BCVA), intraocular pressures (IOP), endothelial cell density (ECD), coefficient of variation in cell-area (CoV), hexagonality (Hex) and central corneal thickness (CCT) were measured preoperatively and postoperatively on day1, day7 and day30. Statistical analysis was done by Anova test. p-value&lt;0.05 was considered significant. Results Mean age of presentation was 65.26±8.3 years. Mean preoperative BCVA (1/60-to-6/60), IOP (16.7±2.3 mm of Hg), CCT (523.93±39.6µ), ECD (2547±302.08cells/mm2), Hex (47.04±5.7%) and CoV (37.57±3.9) changed to BCVA (6/9-to-6/6), IOP (17.5±2.1 mm of Hg), CCT (538.42±36.9µ), ECD (2388.40±339.25cells/mm2), Hex (44.44±5.6%) and CoV (39.09±4.5) at day30 postoperative. Average rate of change at day30 was increase in CCT (2.89%), ECD loss (6.4%), decrease in Hex (4.9%) and increase in CoV (4.6%), though clinically insignificant. No case of endophthalmitis or toxic-anterior segment syndrome seen. Conclusion 0.5% moxifloxacin (0.1 ml) is safe as intracameral antibiotic to prevent postoperative infection in high-risk patients. The reported changes in the corneal parameters were within the range of any routine surgeries of hard senile cataracts. No specific effect could be attributed to ICM.</description><issn>1120-6721</issn><issn>1724-6016</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLAzEUhYMotlZ_gBvJH5iaV5PJUoqPQsGNroebTDKdMi-SKbb_3tSqG8HVvdzznQP3IHRLyZxSpe4pZUQqRhlLm5CKn6EpVUxkklB5nvakZ0dggq5i3BLCiBbsEk24JAsmqJ6ibtUOYEfcd9j2oXPQ4LYPw6Zv-uqAwY8uYAsjhCMUd6Fy4YA_6nGD625MR2hd-PLsa9_0e7B1lxTcuapxdnQl3kAofxPiNbrw0ER38z1n6P3p8W35kq1fn1fLh3VmuSBjBobkxBlKtLc5J3mpBSgtSek0BwrGMWW0EbkW1oBWXPqFzI2nQAgF7jWfIXrKtaGPMThfDKFuIRwKSopjd8Wf7pLn7uQZdqZ15a_jp6wEzE9AhMoV234XuvTDP4mfC0B44g</recordid><startdate>20230301</startdate><enddate>20230301</enddate><creator>Gupta, Simple</creator><creator>Vichare, Nitin</creator><creator>Kumar, Praveen</creator><creator>Agrawal, Mohini</creator><creator>C.M., Anushree</creator><creator>Singh, Manish</creator><general>SAGE Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-4510-0668</orcidid></search><sort><creationdate>20230301</creationdate><title>Impact on corneal morphology after cataract surgery with intracameral moxifloxacin in neglected hard cataracts</title><author>Gupta, Simple ; Vichare, Nitin ; Kumar, Praveen ; Agrawal, Mohini ; C.M., Anushree ; Singh, Manish</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-ab080eb109fc8308d94a7960de93a1abe27b9b4894cba9736f568bf1a001a3f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gupta, Simple</creatorcontrib><creatorcontrib>Vichare, Nitin</creatorcontrib><creatorcontrib>Kumar, Praveen</creatorcontrib><creatorcontrib>Agrawal, Mohini</creatorcontrib><creatorcontrib>C.M., Anushree</creatorcontrib><creatorcontrib>Singh, Manish</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>European journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gupta, Simple</au><au>Vichare, Nitin</au><au>Kumar, Praveen</au><au>Agrawal, Mohini</au><au>C.M., Anushree</au><au>Singh, Manish</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact on corneal morphology after cataract surgery with intracameral moxifloxacin in neglected hard cataracts</atitle><jtitle>European journal of ophthalmology</jtitle><addtitle>European Journal of Ophthalmology</addtitle><date>2023-03-01</date><risdate>2023</risdate><volume>33</volume><issue>2</issue><spage>919</spage><epage>926</epage><pages>919-926</pages><issn>1120-6721</issn><eissn>1724-6016</eissn><abstract>Aim To evaluate corneal morphology after use of 0.5% intracameral moxifloxacin (ICM) in cataract surgery in patients who presented late with hard cataracts. Methods Cross-sectional study conducted from June-2021 to December-2021 at a tertiary eye-care center. 90 patients over 60 years with high-risk characteristics for Covid-19, who presented late with higher grades of nuclear-sclerosis (NS), were included. They underwent phacoemulsification and 0.5%moxifloxacin (0.1 ml) was injected intracamerally at the end of surgery. Best-corrected visual acuity (BCVA), intraocular pressures (IOP), endothelial cell density (ECD), coefficient of variation in cell-area (CoV), hexagonality (Hex) and central corneal thickness (CCT) were measured preoperatively and postoperatively on day1, day7 and day30. Statistical analysis was done by Anova test. p-value&lt;0.05 was considered significant. Results Mean age of presentation was 65.26±8.3 years. Mean preoperative BCVA (1/60-to-6/60), IOP (16.7±2.3 mm of Hg), CCT (523.93±39.6µ), ECD (2547±302.08cells/mm2), Hex (47.04±5.7%) and CoV (37.57±3.9) changed to BCVA (6/9-to-6/6), IOP (17.5±2.1 mm of Hg), CCT (538.42±36.9µ), ECD (2388.40±339.25cells/mm2), Hex (44.44±5.6%) and CoV (39.09±4.5) at day30 postoperative. Average rate of change at day30 was increase in CCT (2.89%), ECD loss (6.4%), decrease in Hex (4.9%) and increase in CoV (4.6%), though clinically insignificant. No case of endophthalmitis or toxic-anterior segment syndrome seen. Conclusion 0.5% moxifloxacin (0.1 ml) is safe as intracameral antibiotic to prevent postoperative infection in high-risk patients. The reported changes in the corneal parameters were within the range of any routine surgeries of hard senile cataracts. No specific effect could be attributed to ICM.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>36052419</pmid><doi>10.1177/11206721221124673</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-4510-0668</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1120-6721
ispartof European journal of ophthalmology, 2023-03, Vol.33 (2), p.919-926
issn 1120-6721
1724-6016
language eng
recordid cdi_crossref_primary_10_1177_11206721221124673
source SAGE Complete
title Impact on corneal morphology after cataract surgery with intracameral moxifloxacin in neglected hard cataracts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T17%3A48%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20on%20corneal%20morphology%20after%20cataract%20surgery%20with%20intracameral%20moxifloxacin%20in%20neglected%20hard%20cataracts&rft.jtitle=European%20journal%20of%20ophthalmology&rft.au=Gupta,%20Simple&rft.date=2023-03-01&rft.volume=33&rft.issue=2&rft.spage=919&rft.epage=926&rft.pages=919-926&rft.issn=1120-6721&rft.eissn=1724-6016&rft_id=info:doi/10.1177/11206721221124673&rft_dat=%3Csage_cross%3E10.1177_11206721221124673%3C/sage_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/36052419&rft_sage_id=10.1177_11206721221124673&rfr_iscdi=true